πŸ‡ΊπŸ‡Έ FDA
Patent

US 8563512

Neprilysin inhibitors

granted A61KA61K31/41A61K31/415

Quick answer

US patent 8563512 (Neprilysin inhibitors) held by Theravance, Inc. expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/41, A61K31/415, A61K31/4155, A61K31/4192